Ilkley, United Kingdom

Peter York

This inventor holds 23 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 1 EPO patent, primarily in Particulate Materials. Top assignees: Nektar Therapeutics, Aps Research Limited, Bradford Particle Design Limited. Active years: 1990-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter York. Retrieved from https://idiyas.com/inventor/peter-york

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 73.9


 

Average Co-Inventor Count = 2.6

ph-index = 9

Forward Citations = 463(Granted Patents)


Location History:

  • Ilkley, W. Yorkshire, GB (1998)
  • West Yorkshire, GB (2002)
  • Illkley, GB (2019)
  • Ilkley, GB (1990 - 2021)

Company Filing History:


Years Active: 1990-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Particulate Materials
Coformulation
Particle Formation
Controlled Particle Size
Sustained-Release Formulations
Salmeterol Xinafoate
Ibuprofen Formulation
Methods and Apparatus
23 patents (USPTO):Explore Patents

Title: Innovations by Peter York in Particulate Materials

Introduction

Peter York, an innovative inventor based in Ilkley, GB, holds an impressive portfolio of 23 patents. His work primarily focuses on the development of particulate materials and their applications, contributing significantly to advancements in drug delivery systems.

Latest Patents

Peter's latest patents showcase his expertise in particulate substances. One notable invention pertains to active substances in particulate form, which discusses methods for preparing them and their potential applications. This invention specifically provides particulate powders that can enhance the delivery process when used with dry powder inhalers (DPI). Another significant patent from Peter involves compositions of particulate coformulation. In this embodiment, the composition includes particles that comprise an active substance and an additive, designed in such a way that the additive concentration increases from the center to the surface of the particle. This innovative approach allows for the formation of a protective surface layer around the active substance, optimizing its delivery and effectiveness.

Career Highlights

Throughout his career, Peter has been associated with notable companies like Nektar Therapeutics and Aps Research Limited. His work in these companies has greatly influenced the field of particulate materials and their delivery mechanisms, marking him as a key contributor to advancements in pharmaceutical technologies.

Collaborations

Peter has collaborated with several talented individuals in the field, including Mazen H. Hanna and Andreas Kordikowski. These partnerships have facilitated the exchange of innovative ideas and advancements in the development of particulate coformulations.

Conclusion

Peter York's contributions to the field of particulate materials and their applications in drug delivery are significant, as evidenced by his numerous patents and collaborations. His ongoing dedication to innovation in this area promises to continue shaping the future of pharmaceutical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…